p53 gene replacement for cancer: Interactions with DNA damaging agents

Acta Oncologica

Volumn 40, Issue 6, 2001, Pages 739-744

  Roth, J A ^a   Grammer, S F ^a   Swisher, S G ^a   Komaki, R ^a   Nemunaitis, J ^a   Merritt, J ^a   Meyn, R E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DNA; GENES; RADIOTHERAPY; TOXICITY; TUMORS;

TUMOR REGRESSION;

GENETIC ENGINEERING;

ANTINEOPLASTIC AGENT; DNA DAMAGING AGENT; PROTEIN P53; UNCLASSIFIED DRUG;

ADENOVIRUS; CANCER; CELL DEATH; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DNA DAMAGE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; IMAGE ANALYSIS; IMMUNE RESPONSE; PRIORITY JOURNAL; TUMOR; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY;

EID: 0035184722     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860152619160     Document Type: Conference Paper

References (42)

1. Radiation induced apoptosis: Relevance to radiotherapy
2. Apoptosis and response to radiation: Implications for radiation therapy
3. Apoptosis in murine tumors treated with chemotherapy agents
4. Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection
5. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
6. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer
7. p53 expression and prognosis in gastric carcinoma
8. The approaching era of the tumor suppressor gene
9. Tumor suppressor genes: The puzzle and the promise
10. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
11. The bcl-2 protein family: Arbiters of cell survival
12. Tumor suppressor p53 is a direct transcriptional activator of human bax gene
13. The p53 pathway and apoptosis
14. ATM associates with and phosphorylates p53: Mapping the region of interaction
15. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia
16. Enhanced phosphorylation of p53 by ATM in response to DNA damage
17. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis
18. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus
19. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation
20. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer
21. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer
22. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts
23. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity
24. High efficiency in vivo gene transduction following intralesional solid tumor injection of a recombinant adenovirus vector
25. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
26. Adenovirus-mediated p53 gene transfer in advanced non-small cell lung cancer
27. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53
28. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line
29. Wild-type p53 induces apoptosis of myeloid leukemic cells that are inhibited by interleukin-6
30. Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer
31. Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral-mediated transfer of the wild-type p53 gene
32. Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells
33. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas
34. Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: Can they predict treatment response and clinical outcome?
35. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction
36. Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis
37. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cells lines
38. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage
39. No association between radiosensitivity and TP53 status, G(1) arrest or protein levels of p53, myc, ras or raf in human melanoma lines
40. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small cell lung cancer
41. A phase II trial of adenoviral mediated p53 gene transfer (RPR/INGIN 201) in conjunction with radiation therapy in patients with localized non-small cell lung cancer (NSCLS)
42. Roles of p53 C-terminal domain in distribution and ubiquitination